Evidence map›Paper›PMID 26197779›Full record

ArticleBMC public health2015

The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany.

Markus Loeffler, Christoph Engel, Peter Ahnert, Dorothee Alfermann, Katrin Arelin, Ronny Baber, Frank Beutner, Hans Binder, Elmar Brähler, Ralph Burkhardt and 47 more

Abstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 196 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
196citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

196 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Trial
  11. Article
  12. Observational
  13. Article
  14. ConstitutionalJCO precision oncology · 2026
    Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

136 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

57 authors.

Markus LoefflerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. markus.loeffler@imise.uni-leipzig.de.
Christoph EngelLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Peter AhnertLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Dorothee AlfermannLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Katrin ArelinLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Ronny BaberLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Frank BeutnerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Hans BinderLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Elmar BrählerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Ralph BurkhardtLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Uta CeglarekLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Cornelia EnzenbachLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Michael FuchsLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Heide GlaesmerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Friederike GirlichLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Andreas HagendorffLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Madlen HäntzschLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Ulrich HegerlLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Sylvia HengerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Tilman HenschLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Andreas HinzLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Volker HolzendorfLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Daniela HusserLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Anette KerstingLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Alexander KielLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Toralf KirstenLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Jürgen KratzschLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Knut KrohnLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Tobias LuckLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Susanne MelzerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Jeffrey NettoLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Matthias NüchterLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Matthias RaschpichlerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Franziska G RauscherLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Steffi G Riedel-HellerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Christian SanderLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Markus ScholzLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Peter SchönknechtLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Matthias L SchroeterLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Jan-Christoph SimonLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Ronald SpeerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Julia StäkerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Robert SteinLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Yve Stöbel-RichterLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Michael StumvollLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Attila TarnokLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Andrej TerenLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Daniel TeupserLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Francisca S ThenLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Anke TönjesLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Regina TreudlerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Arno VillringerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Alexander WeissgerberLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Peter WiedemannLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Silke ZachariaeLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Kerstin WirknerLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Joachim ThieryLIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe LIFE-Adult-Study is a population-based cohort study, which has recently completed the baseline examination of 10,000 randomly selected participants from Leipzig, a major city with 550,000 inhabitants in the east of Germany. It is the first study of this kind and size in an urban population in the eastern part of Germany. The study is conducted by the Leipzig Research Centre for Civilization Diseases (LIFE). Our objective is to investigate prevalences, early onset markers, genetic predispositions, and the role of lifestyle factors of major civilization diseases, with primary focus on metabolic and vascular diseases, heart function, cognitive impairment, brain function, depression, sleep disorders and vigilance dysregulation, retinal and optic nerve degeneration, and allergies. METHODS/

designThe study covers a main age range from 40-79 years with particular deep phenotyping in elderly participants above the age of 60. The baseline examination was conducted from August 2011 to November 2014. All participants underwent an extensive core assessment programme (5-6 h) including structured interviews, questionnaires, physical examinations, and biospecimen collection. Participants over 60 underwent two additional assessment programmes (3-4 h each) on two separate visits including deeper cognitive testing, brain magnetic resonance imaging, diagnostic interviews for depression, and electroencephalography. DISCUSSION: The participation rate was 33 %. The assessment programme was accepted well and completely passed by almost all participants. Biomarker analyses have already been performed in all participants. Genotype, transcriptome and metabolome analyses have been conducted in subgroups. The first follow-up examination will commence in 2016.

Indexed as

Health StatusHealth Status IndicatorsAdultAgedCohort StudiesFemaleGermanyHealth SurveysHumansMaleMiddle AgedPhysical ExaminationPopulation SurveillanceResearch DesignUrban Population

Identifiers

PMID26197779
PMCPMC4509697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.